- Philogen introduce la piattaforma per il Whistleblowing (Direttiva EU 2019/1937)
- Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities
- Following the announcements of this morning, Philogen management is inviting you to a Webinar on December 5 at 15:00 GMT | 16:00 CET.
- Philochem AG (a company of the Philogen group) announces the completion of central radiolabeling activities for the therapeutic use of OncoFAP-23
- Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors